Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity

被引:15
作者
Elhaji, YA
Stoica, I
Dennis, S
Purisima, EO
Trifiro, MA
机构
[1] McGill Univ, Dept Human Genet, Lady Davis Inst Med Res, Natl Res Council Canada, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Natl Res Council Canada, Dept Human Genet, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Natl Res Council Canada, Dept Med, Montreal, PQ H3T 1E2, Canada
[4] McGill Univ, Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H3T 1E2, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1093/hmg/ddl009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural studies of the ligand-binding domain (LBD) of several steroid receptors have revealed that the dynamic properties of the C-terminal helix 12 (H12) are the major determinant of the activation mode of these receptors. H12 exhibits high mobility and different conformations in the absence of ligand. Upon ligand binding, H12 is stabilized in a precise position to seal the ligand-binding pocket and finalize the assembly of the activation function (AF-2) domain. In this study, we investigated the role of the conserved proline 892 of the androgen receptor (AR) in directing the dynamic location and orientation of the AR-H12. We used a combined approach including kinetic and biochemical assays with molecular dynamic simulations to analyze two substitutions (P892A and P892L) identified in individuals with complete androgen insensitivity syndrome. Our analyses revealed distinct mechanisms by which these substitutions impair H12 function resulting in severely defective receptors. The AR-P892A receptor exhibited reduced ligand binding and transactivational potential because of an increased flexibility in H12. The AR-P892L substitution renders the receptor inactive due to a distorted, unstructured and misplaced H12. To confirm the mutants' inability to stabilize H12 in an active position, we have developed a novel in vivo assay to evaluate the accessibility of the H12-docking site on the AR-LBD surface. An extrinsic AR-H12 peptide was able to interact with wild-type and mutant LBDs in the absence of ligand. Ligand-induced proper positioning of the intrinsic H12 of wild-type AR prevented these interactions, whereas the misplacement of the mutants' H12 did not. Proline at this position may be critical for H12 dynamics not only in the AR, but also in other nuclear receptors where this proline is conserved.
引用
收藏
页码:921 / 931
页数:11
相关论文
共 46 条
[1]   Nuclear hormone receptor co-repressors [J].
Baniahmad, A .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 93 (2-5) :89-97
[2]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[3]   Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2) [J].
Berrevoets, CA ;
Doesburg, P ;
Steketee, K ;
Trapman, J ;
Brinkmann, AO .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (08) :1172-1183
[4]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[5]   Genotype versus phenotype in families with androgen insensitivity syndrome [J].
Boehmer, ALM ;
Brüggenwirth, H ;
Van Assendelft, C ;
Otten, BJ ;
Verleun-Mooijman, MCT ;
Niermeijer, MF ;
Brunner, HG ;
Rouwé, CW ;
Waelkens, JJ ;
Oostdijk, W ;
Kleijer, WJ ;
Van der Kwast, TH ;
De Vroede, MA ;
Drop, SLS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (09) :4151-4160
[6]   Structural basis for antagonism and resistance of bicalutamide in prostate cancer [J].
Bohl, CE ;
Gao, WQ ;
Miller, DD ;
Bell, CE ;
Dalton, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) :6201-6206
[7]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[8]  
CASE DA, 2002, AMBER7 USER MANUAL
[9]   Resistance to thyroid hormone [J].
Chatterjee, VKK .
HORMONE RESEARCH, 1997, 48 :43-46
[10]   Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding [J].
Costantino, G ;
Entrena-Guadix, A ;
Macchiarulo, A ;
Gioiello, A ;
Pellicciari, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (09) :3251-3259